EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Case-based review: Craniopharyngioma treated with intracystic peginterferon

Gonzalo Nicolás Salagre, Sara Iglesias, María Isabel Martínez-León, Marta Cortés, Iván Federico Narváez, Bienvenido Ros

Child's Nervous System · 2025

DOI: 10.1007/s00381-025-07070-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Child's Nervous System, 2025. Verfasst von Gonzalo Nicolás Salagre und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hospital Regional Universitario de Málaga, Málaga, Spain. gonzalo.salagre97@gmail.com. Hauptthemen laut MEDLINE: Craniopharyngioma, Pituitary Neoplasms, Interferon-alpha, Polyethylene Glycols. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Craniopharyngiomas are benign tumors with a challenging management due to the excessive morbidity of the classical therapeutic approaches. This has led to the current trend of a multimodal approach with more conservative surgical options. CASE REPORT: We present the case of a 6-year old patient diagnosed with a giant multicystic and rapidly recurrent craniopharyngioma, showing the current trends towards a multimodal therapeutic approach with less aggressive surgical options. We emphasize the use of two different intracystic cycles of a new formulation of pegylated 2a interferon. We make a review of the available literature focusing on historical and current treatment options. CONCLUSION: Craniopharyngiomas remain a challenge due to the morbidity caused by both the disease and its treatment. The current trend towards a more conservative approach has many alternative treatment options, with intracystic pegyladed 2a interferon being a safe and effective choice, even in consecutive administrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CraniopharyngiomaPituitary NeoplasmsInterferon-alphaPolyethylene GlycolsAntineoplastic AgentsHumansChildRecombinant ProteinsMaleMagnetic Resonance Imaging

Stichwörter der Autor:innen

CraniopharyngiomaIntracysticPeginterferon

Substanzen

Interferon-alphaPolyethylene GlycolsRecombinant Proteinspeginterferon alfa-2aAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Hospital Regional Universitario de Málaga, Málaga, Spain. gonzalo.salagre97@gmail.com.
  • Department of Neurosurgery, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Department of Radiology, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Pediatric Oncology Unit, Hospital Materno-Infantil de Málaga, Málaga, Spain.

Zitieren

APA

Salagre, G. N., Iglesias, S., Martínez-León, M. I., Cortés, M., Narváez, I. F., & Ros, B. (2025). Case-based review: Craniopharyngioma treated with intracystic peginterferon. Child's Nervous System. https://doi.org/10.1007/s00381-025-07070-2

Vancouver

Salagre GN, Iglesias S, Martínez-León MI, Cortés M, Narváez IF, Ros B. Case-based review: Craniopharyngioma treated with intracystic peginterferon. Child's Nervous System. 2025. doi:10.1007/s00381-025-07070-2

BibTeX
@article{Salagre2025,
  author = {Salagre, Gonzalo Nicolás and Iglesias, Sara and Martínez-León, María Isabel and Cortés, Marta and Narváez, Iván Federico and Ros, Bienvenido},
  title = {Case-based review: Craniopharyngioma treated with intracystic peginterferon},
  journal = {Child's Nervous System},
  year = {2025},
  doi = {10.1007/s00381-025-07070-2}
}
Kostenlos starten →